Expression of the stem cell marker nestin in pre/hypertrophic chondrocytes in osteochondroma.

Abstract	The pathogenesis of osteochondroma, the most common benign bone tumour, is not fully known. To date, regulation of nestin protein levels in osteochondromas and normal growth plates has not been reported. This study used immunohistochemical analysis to detect nestin protein levels in 48 osteochondromas and 13 normal growth plates (eight fetal and five postnatal). Nestin protein was mainly restricted to prehypertrophic and hypertrophic chondrocytes in osteochondroma. Nestin levels were significantly higher in osteochondromas in adolescents (age range 4 - 18 years, n = 32) than in osteochondromas in young adults (age range 20 - 28 years, n = 11), and significantly higher in osteochondromas in young adults than in those in older adults (age range 40 - 77 years; n = 5). Nestin protein was not present in normal growth plates. The presence of nestin protein parallels the biological behaviour of osteochondromas and is restricted to prehypertrophic and hypertrophic chondrocytes, indicating that these nestin-positive cells may be central to osteochondroma development.
Authors	K Du, Y Peng, L Zhang, A Liang, D Huang
Journal	The Journal of international medical research (J Int Med Res) Vol. 39 Issue 2 Pg. 348-57 ( 2011) ISSN: 1473-2300 [Electronic] England
PMID	21672338 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Biomarkers, Tumor Intermediate Filament Proteins NES protein, human Nerve Tissue Proteins Nestin
Topics	Adolescent Adult Aged Biomarkers, Tumor (metabolism) Child Child, Preschool Chondrocytes (metabolism, pathology) Female Growth Plate (metabolism, pathology) Humans Hypertrophy Immunohistochemistry Intermediate Filament Proteins (metabolism) Male Middle Aged Muscle, Skeletal (metabolism, pathology) Nerve Tissue Proteins (metabolism) Nestin Osteochondroma (metabolism, pathology) Stem Cells (metabolism) Treatment Outcome Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!